In February 2018 the U.S. Food and Drug Administration (FDA) made a giant leap in modernizing its approach to its evaluation for new drugs for Alzheimer’s disease and other neurologic disease. [...]
A study recently conducted by The University of Exeter Medical School analyzed the data on stroke and dementia risk from 3.2 million individuals around the world. The data revealed that the link [...]
When contesting or challenging a will, modern courts use the Greenwood-Baker Test to determine whether a decedent possessed sufficient testamentary capacity to execute a will.
